IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Wrong Kong, that's a naively dense way of putting it, like we have glassed house ourselves to the negative, there frigging obvious as can be, we ain't been living under a rock.
But don't hang a guy because he is doing his upmost to bring positive, and add depth to the losses by trying to give you details of costs, the lab costs he spoke about, well I'd never of known about leasing etc
I just see loss, so it's nice for his effort to show it on a less black and white, this is all just loss loss loss angle.
No ones right or wrong
Dustyslay
Obviously you don’t like any of my posts which is fine .
I feel that yourself and one or two more on here don’t want to believe anything negative on here nor want to accept any negative comments.
You only want to believe this can be a unicorn and you want to rebuff anyone that may not think otherwise.
Time will tell who is right, but don’t get angry if it dosent
Givemesunshine
How ever you look at the figures. The company is loosing a fortune.
Regarding my ability and knowledge to trade shares that you believe I’m not very good at.
You bought some more the other day, I personally think that was a bad decision but we will have to wait and see if it was or not.
Good luck if it goes well !!
My gut feeling is this company needs money by the end of the year.
A fund raise is inevitable.and I believe we need one in the autumn , next year as you say is too far away.
You say burrows claims they are selling 4.25 shares a day now.
Well that’s still only 130 ish a month.
No where near enough.
Since the H1 results we now have more labs,
What are the running costs of these ?
Have we employed more staff as well ?
What extra costs have Oxford acquired since April 1st ?
Burrows has mislead the markets on more than one occasion!
His wages is more than last years revenue for the entire company , totally unacceptable!!
The tests have not been validated and are way too expensive
This is why the NHS can’t interact with the company nor buy their tests.
I will leave it there for the moment but unless seriously positive news on sales starts filtering through very quickly
This share will slowly keep dropping .
I think we're all dissapointed here, and trying to make sense of it all. The losses, the sales the revenues and work out what we can hopefully expect.
I appreciate some are angry but I appreciate the effort he put in to gather a breakdown, cover some costs maybe not seen by the naked eye and snippets of lab costs etc. He obviously put a bit of effort to present such. Even under the heavy duress of your 2 questioning.
I think a little respect as a show of faith would be beneficial to the argument, and maybe from both sides.
Yes he maybe got a bit tongue and cheek, but it's not like we ain't all done that when I'm similar position
Seriously flamed???, seriously.
Because he actually went and brought out a detailed breakdown of his calculations and readings of the report, as a rebuttal to a "I'm not seeing it here, it's says this, you are wrong , accusation.
I think your over looking his effort to provide such
Btw they are points anyone can comment on.
Chill out, they are perfectly legitimate points I am raising and yes it's guesswork to judge but this is a discussion board after all and Kong has been seriously flamed for his views which imo is wrong but seems acceptable to you .
New uncle,
I think that's a little unnecessary, he isn't a performing monkey, he was openly positive at first about the RNS, within his right and openly shared findings he thought pertinent but was consistently challenged by people with less favourable outcomes. Mainly due to aggrieved sentiment to the board, and deflected that anger towards a fellow investor.
He has no reason to perform these tasks, and has offered his take and his calculations as you have yours, if you disagree then disagree.
But less of the disrespect it's getting all a bit nonsensical now.
We are in the dark on future predictions, as we have been from the start, and it's no members fault negative or positive feelings aside.
Thanks
And what are challenging markets for their tests please?
Ok so on what basis could obd at least break even.. how many tests a day are needed every day. Is it 10, 20, 30.... Etc
Kong I'm calling it
Game set MATCH
YOUR giving me sunshine
Another AIM bag of 💩
Kong - there nothing to agree about - you clearly dont know the diffence between Oerating losses and cash outflow
From the accounts - Financial position
Cash and fixed term deposits at 31 March 2024, which exclude the proceeds from the £9.9m (before fees) fundraising completed in April 2024, were £1.19m (31 March 2023: £3.62m, 30 September 2023: £5.25m), reflecting the overall reduction in cash for the period of £4.06m.
In simple terms
If you look a H1 last year the cash used (£5.91m )was much higher than the Operating Loss - (£4.78m) so would you say they used 4.78m or 5.91m? (they used £5.91m not £4.78 )
This is because not all money you use can be claimed as losses. Say you buy a factory for £1 milion or take out a lease or buy equpment and plant - you spend the cash but its not a loss, goes on the balance sheet.. over time you clain depreciation or appreciation of those assets, but the go on the account as a loss (of value) but not cash , there are tricks , such as dont pay a £300k bill before year end , looks like more cash, but then liabilites increase etc
If you look a H1 this year the cash used (£4.061m )was much lower than the Operating Loss - (£5.9m) so would you say they used 4.06 m or 5.91m?
It also ties into the funds they had left.. they would have run out for mony before year end . they started with £5.25 million and ended with £1.19 - how they spend six million 😂😂😂😂😂
Joking aside if you dont get the above you should think carefully before buying and selling shares - could make some very bad choises
Givemesunshine
Can’t say they are raiding the cash flow figures
But it does appear to show they are burning £6k in 6 months
I know you don’t agree do we will agree to disagree.
But burrows has said on one or two occasions false information and I really don’t think I trust the man.
From the figures 4.25 sales a day dosent stack up and even if it did that’s only 127 a month
I believe they need to sell aprox 1500 a month to make a profit
1000 a month might or might not be break even, which is not good enough
I know in coming across over positive - thats not the case - big there was some big thing in that presentation - One thing almost totally overlooked on here from yesterday CIRRT - £9million Grant funded, with a pretty urgent timeline IMO
OBD down to the last 2 on the shortlist, the only applicant with a test Cirt ready to use? This process started in Jan24,
Next Steps
Final meeting 26th -27th June 23
Funding July23
Project Start August 2024
https://www.ukri.org/opportunity/cancer-immunotherapy-response-research-platform/
This is really big news (if they get it) but if they dont , i'm not sure who will. all the talk about transform - this one is very relevant - Ive read all of the Cirrt page and scope documents - it fits like cinderellas shoe (on cinderella😊)
Kong if you believe they are frauding the cashflow statement and making up the test numbers , then there isnt really anything I can respond to with that😊but It does happen.
Kong - its on the last page of the presentation also highlights the differences between Overval P/L and Cash burn
cut n paste below - note how the operational loss was less than the cash burn in H12023 - and the opposite this H1
H1 2023 H1 FY2023 H1 FY2024
Operating loss (5,993) (4,758) (10,168)
Movement in cash and term deposits (Excluding fundraise)
(4,063) (5,914) (9,892)
Give me sunshine
I’m sorry but I’m not getting your numbers or cash burn rate.
I’m going to stick with my predictions and still believe funding needed by the autumn.
I know you’ve said Burtows has implied sales of 4 a day but his credibility is in the gutter as far as I’m concerned from past RNS
The screen jump thing has commenced on this site again!!! Half posts unfinished!!...
I believed in the science that was presented and the sp performance reflected on my initial investment as many did.
So these additional costs factored in will be missed by myself, and rely on better minds containing these facts to be accredited to board members.
A decision not entirely good for investing, but one I shall rely on as things progress.
Thanks for your continued input on these matters
Givenmesunshine,
I'll agree this investment is beyond my means and expertise in these fields. I believed in the science behinfm
This will be percentage of a penny within a month!
Defiately a percentage of cost added to staff / power and keep UK all running (US already baked in) but a reduction on the CAPEX spent in H1 now that the uk Lab is built / Completed just after H1 (there might be some numbers on that hidden somewhere) then we have PSE at £750 a pop coming in at a growing rate.
To suggest for Dec would suggest Cash burn goes instantly up to over a £1million a month, when in fact the cash used has dropped dropped the highs of H123 in both H2-23 and H1 24.. not saying it will come down , I dint see anything to suggest to will shoot up so dramatically myself.
So on that basis more costs to be added into 2024 monthly figures which I know is obvious but like you say not cheap and should be taken into consideration in trying to assess company cash burn v money in the bank. I am still inclined to expect the company to require more funds before Dec 2024. Even the FD said they don't know when/if etc etc.
NU its a good question - We cant really tell exactly - I have alot of experience in test labs - big cost like leasing are conbined in the account but were completed last finacial year, so aready in the numbers but will be ongoing. equipment etc may have been purchased, but most likely leased with calibration, maintenance contracts inplace, power and cooling and Accredation costs , plus the staff .. Lab tech isnt a very high paying job. say £50k-£55k.. cna only guess from what ive seen so far
Give me sunshine indeed,
You have been a fresh addition to this board these last coming weeks, bringing fresh input to a somewhat stagnant sentiment.
Appreciate your time taking to read, produce and carefully articulate the facts and have not risen to bait.
Gl